Review
doi: 10.1023/a:1025871231346.
Current and future trends in colorectal cancer screening
Affiliations
- PMID: 15000154
- DOI: 10.1023/a:1025871231346
Item in Clipboard
Review
Current and future trends in colorectal cancer screening
Cancer Metastasis Rev.
2004 Jan-Jun.
Abstract
Current modalities for colorectal cancer screening include fecal occult-blood testing, flexible sigmoidoscopy, colonoscopy, and double-contrast barium enema. Among these, colonoscopy is becoming the dominant modality, in light of its efficacy and continuing technical refinements. Emerging technologies, such as stool DNA tests and virtual colonoscopy, hold promise for the future but cannot be recommended for screening at present.
Similar articles
-
Screening for colorectal cancer--now and the near future.Semin Oncol. 2005 Feb;32(1):3-10. doi: 10.1053/j.seminoncol.2004.09.031. Semin Oncol. 2005. PMID: 15726501 Review.
-
Alternatives to colonoscopy for population-wide colorectal cancer screening.Hong Kong Med J. 2016 Feb;22(1):70-7. doi: 10.12809/hkmj154685. Epub 2016 Jan 8. Hong Kong Med J. 2016. PMID: 26744124 Review.
-
Sensitivity of diagnostic examinations for colorectal polyps.Tech Coloproctol. 2004 Dec;8 Suppl 2:s273-5. doi: 10.1007/s10151-004-0175-0. Tech Coloproctol. 2004. PMID: 15666105 Review.
-
The Quebec Association of Gastroenterology position paper on colorectal cancer screening - 2003.Can J Gastroenterol. 2004 Aug;18(8):509-19. doi: 10.1155/2004/327858. Can J Gastroenterol. 2004. PMID: 15372115
-
Current colorectal cancer screening strategies: overview and obstacles to implementation.Rev Gastroenterol Disord. 2002;2 Suppl 1:S2-11. Rev Gastroenterol Disord. 2002. PMID: 12439393 Review.
Cited by
-
Changes in lipids composition and metabolism in colorectal cancer: a review.Lipids Health Dis. 2019 Jan 26;18(1):29. doi: 10.1186/s12944-019-0977-8. Lipids Health Dis. 2019. PMID: 30684960 Free PMC article. Review.
-
Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007.Am J Public Health. 2012 Sep;102(9):1791-7. doi: 10.2105/AJPH.2011.300393. Epub 2012 Jan 19. Am J Public Health. 2012. PMID: 22873481 Free PMC article.
-
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.Sci Rep. 2019 Dec 27;9(1):20198. doi: 10.1038/s41598-019-55952-8. Sci Rep. 2019. PMID: 31882610 Free PMC article.
-
Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer.Cancers (Basel). 2021 Mar 17;13(6):1351. doi: 10.3390/cancers13061351. Cancers (Basel). 2021. PMID: 33802764 Free PMC article.
-
Metabolomics analysis of amino acid and fatty acids in colorectal cancer patients based on tandem mass spectrometry.J Clin Biochem Nutr. 2023 Sep;73(2):161-171. doi: 10.3164/jcbn.22-110. Epub 2023 Sep 1. J Clin Biochem Nutr. 2023. PMID: 37700848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical